INVITATION FOR TECHNOLOGICAL COOPERATION
Company: BABY'S BREATH LTD.
DOCUMENT STRUCTURE:
CONTACT DATA
| Organization: | BABY'S BREATH LTD. |
| Contact: |
Name: Mr. Gilad Golan Position: CEO |
| Address: |
5 Hahadas St., North Industrial Area P.O.Box: 42 Or Akiva ISRAEL, 30600 Telephone: 04-6262551 Fax: 04-6262552 Email: bbreath@bbreath.com WEB site: www.bbreath.com |
GENERAL INFORMATION
Established: 2001
Type:
Graduated from Technological Incubator
Ownership: Private
Parent: Yozmot Granot Initiative Center
Core business
Drug administration for infants by inhalation. Advanced
Employees: 8 Overview
BABY'S BREATH LTD. is a new medical device company established by
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
Inhalation Technologies.
Main Markets:
Infants and elderly population suffering from pulmonary diseases or taking medication deliverable through inhalation.
leading experts and highly experienced professionals dedicated to
the development, production and distribution of breakthrough
inhalation technologies that meet existing medical and market
needs.
The company's vision is to enhance patient's wellbeing by
improving the effectiveness of treatment through more user
compliant products.
More acceptable treatment technologies with better symptom
control and easier treatment administration will lead to faster
health improvement, and help reduce hospital and outpatient
costs.
BABY'S BREATH's flagship product, BabyAir is a unique solution to
the problem of non-compliance of babies to receive aerosol-based
medications through traditional face masks.
Demonstrating the company's ability to develop innovative
approaches to long unsolved problems, BabyAir employs an
ingenious 'hood' technique that creates a safe, easy & highly
effective way to directly deliver inhaled medications to infants
without physical contact, whether they are awake or asleep.
Extensive clinical trials suggest that BabyAir is far more
effective than traditional masks, allowing infants to recover
faster because they actually receive and absorb the optimum dose
of medication.
BabyAir is the first of a number of breakthrough inhalation
devices that BABY'S BREATH LTD. intends to introduce to the
market especially designed for the millions of patients with
respiratory problems.
MATIMOP ADDRESS:
Liaison: Mr. Uzi Bar-Sadeh
Internet site: http://www.matimop.org.il
Email: uzi@matimop.org.il
Mail: POBox: 50364 Tel Aviv Israel 61 500
Fax: ++ 972 3 5177655